Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:Pzena is Hit With Another IPO Suit Not Rated 1.0 Email Routing List Email & Route  Print Print
Wednesday, January 16, 2008

Pzena is Hit With Another IPO Suit

Reported by Erin Kello

New York City-based Pzena Asset Management has been slapped with yet another lawsuit relating to its October IPO. Cohen, Milstein, Hausfeld & Toll, P.L.L.C. has filed suit against Pzena in the Southern District of New York for allegations that the company and its founder, Richard Pzena, issued numerous materially false and misleading statements which caused Pzena’s securities to trade at artificially inflated prices. The lawsuit is seeking class action status.

Baltimore-based Brower Priven (see Pzena Slapped with Suit Post-IPO," November 30, 2007) and New York-based Abraham, Fruchter & Twersky (see "Fund Outflows Trigger a Lawsuit for Pzena," November 26, 2007) also have pending suits involving the company's IPO.

Brower Priven's complaint alleges that Pzena and its executives issued materially false and misleading statements that artificially inflated the market price of the firm's securities. Abraham, Fruchter & Twersky's complaint alleges that Pzena did not disclose net redemptions in the $8-billion John Hancock Classic Value Fund, which is subadvised by Pzena, at the time of its IPO.


Company Press Release

The law firm Cohen, Milstein, Hausfeld & Toll, P.L.L.C. has filed a lawsuit in the United States District Court for the Southern District of New York on behalf of its client and on behalf of other similarly situated purchasers of Pzena Investment Management, Inc. (“Pzena” or the “Company”) (NYSE:PZN) common stock pursuant and/or traceable to the Company’s October 24, 2007 Initial Public Offering (the “IPO”). The complaint charges Pzena and Richard C. Pzena with violations of the Securities Act of 1933 (the “Securities Act”).

Specifically, the complaint alleges that, in connection with the IPO, defendants issued numerous materially false and misleading statements which caused Pzena’s securities to trade at artificially inflated prices. As alleged in the complaint, the Company’s registration statement for the IPO failed to disclose a pattern of net redemptions in the largest mutual fund advised by Pzena, which existed at the time of the IPO. The subsequent disclosure of these facts three weeks later resulted in the price of the Company’s common stock declining, causing Plaintiff and the other members of the Class to suffer damages.

If you are a member of the class, you may, no later than January 22, 2007, request that the Court appoint you as Lead Plaintiff of the class. Any member of the purported class may move the Court to serve as Lead Plaintiff through counsel of their choice or may choose to remain an absent class member. Cohen, Milstein, Hausfeld & Toll, P.L.L.C. has significant experience in prosecuting investor class actions and actions involving securities fraud. The firm has offices in Washington, D.C., New York, Philadelphia, Chicago, San Francisco, and London, and is active in major litigation pending in federal and state courts throughout the nation. You may visit the firm’s website at www.cmht.com.

The firm’s reputation for excellence has been recognized on repeated occasions by courts which have appointed the firm to lead positions in complex multi-district or consolidated litigation. Cohen, Milstein, Hausfeld & Toll, P.L.L.C. has taken a lead role in numerous important cases on behalf of defrauded investors, and has been responsible for a number of outstanding recoveries which, in the aggregate, total in the billions of dollars.
 

Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

1.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2026: Q2Q1
2025: Q4Q3Q2Q1
2024: Q4Q3Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly


  1. WE South - TopGolf Showdown (Nashvile), April 1
  2. WE South - TopGolf Showdown (Fort Myers), April 1
  3. WE South - TopGolf Showdown (Atlanta), April 1
  4. WE South - TopGolf Showdown (Charlotte), April 1
  5. MFDF webinar - Strategic ETF Launch and Listing Oversight for Independent Fund Boards, April 7
  6. MFDF webinar - MPI's Annual Survey of Investment Firm Profitability and Economies of Scale, April 8
  7. IDC Foundations For Fund Directors, Apr 8-9
  8. IMEA webinar - The Future of Sales in the Intermediary Channel and the Evolving Role of the Internal Salesperson, April 8
  9. IDC webinar - Alternative Investments Briefing For Fund Directors: Introduction to Interval Funds, April 13
  10. MFDF Director Discussion Series - Open Forum, April 14
  11. WE SoCal - DTLA Networking Lunch, April 15
  12. MFDF Director Discussion Series - Open Forum, April 16
  13. Tiburon CEO Summit L, Apr 20-22
  14. 2026 MMI Thrive Forum, Apr 21-22
  15. WE PNW - Wealth and Finance Career Conference, April 22
  16. IMEA Distribution Summit, April 22
  17. Nicsa webinar - From AI Hype to Business Impact: Asset Management Insights, Applications and Governance, April 22
  18. MFDF Spotlight webinar - Key Findings and Insights from MFDF's Fund Board Composition Survey, April 22
  19. IDC Fund Directors Workshop, April 29 - May 1
  20. ICI Leadership Summit, April 29 - May 1
  21. IMEA Alternatives Roundtable, April 30
  22. 7th Annual Expect Miracles Foundation Distance Challenge, May 12-19
  23. New York Sohn Investment Conference, May 12
  24. Nicsa webinar - Scaling Operations In a Data-Intensive World, May 13
  25. Envestnet Elevate 2026, May 19-20
  26. ICI ETF Conference, Jun 8-10




©All rights reserved to InvestmentWires, Inc. 1997-2026
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use